Inventor · disambiguated record
Huifeng Niu
Also filed as: NIU HUIFENG
5 granted patents·5 pending applications·30 citations·filing 1998–2024
75Inventor score
Files withMILLENNIUM PHARM INC4ROCHE GLYCART AG2HOFFMANN LA ROCHE1NIU HUIFENG1TAKEDA PHARMACEUTICALS CO1
Top patents by PatentIndex Score
10 records- 0190US11214622B2Antibodies specific for DR5 and methods of useROCHE GLYCART AG·Filed 2018·Granted Jan 4, 2022·6 cites·13 claims
- 0290US9926379B2Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5ROCHE GLYCART AG·Filed 2014·Granted Mar 27, 2018·17 cites·28 claims
- 0385US9724354B2Combination of catalytic mTORC1/2 inhibitors and selective inhibitors of Aurora A kinaseMILLENNIUM PHARM INC·Filed 2014·Granted Aug 8, 2017·7 cites·2 claims
- 0472US2025043353A1Biomarkers of response to selective inhibitors of aurora a kinaseMILLENNIUM PHARM INC·Filed 2024·Application pending·0 cites
- 0552US9409961B2Cell penetrating peptides to target EIF4EHOFFMANN LA ROCHE·Filed 2013·Granted Aug 9, 2016·0 cites·14 claims
- 0651US2018117060A1Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinaseMILLENNIUM PHARM INC·Filed 2017·Application pending·0 cites
- 0750US12048699B2Cancer treatment methods based on TP53 mutation status and hypermutationTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Jul 30, 2024·0 cites·10 claims
- 0847US2019194750A1Biomarkers of response to selective inhibitors of aurora a kinaseMILLENNIUM PHARM INC·Filed 2016·Application pending·0 cites
- 0942US2008207563A1Method for inhibiting proliferation of tumor cellsNIU HUIFENG·Filed 2008·Application pending·0 cites
- 1026US2001010922A1Cloning and uses of the genetic locus bcl-6Filed 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Huifeng Niu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →